Skip to main content

Table 1 Features of VCI, as related to experimental models considered

From: Translational models for vascular cognitive impairment: a review including larger species

 

MCAo

Rats, mice

MCAo

Sheep

Chronic hypo-perfusion

Rats, mice

Chronic hypo-perfusion

Baboons

HHCy

Rats, mice

Chronic HT:

SHRSP

Chronic HT: monkeys

Aged dogs

CADASIL mice

Cognitive changes: executive function, attention, processing speed, apathy/reward seeking, memory decline

deficits in spatial and recognition memory; passive avoidance.

post-stroke apathy; higher cognitive function NR

Working memory and reference memory deficits

NR

Impaired spatial learning, working memory

Spatial memory impaired

Reduced executive function, attention, short-term memory

Executive function, spatial learning and memory; visuo-spatial function, simple associative learning; open field activity, anxiety, dis-orientation; restlessness

NR

Sub-cortical motor symptoms: Impaired gait, balance, posture

Sensori-motor deficits. Severity depends on lesion size.

Sensori-motor deficits reflecting lesion size and location

motor deficits on rotarod (GCAS mice).

NR

NA

Sensori-motor deficits. Severity depends on lesion type, location, size

NA

NR

Motor deficits in some aged animals

No motor deficits reported for BCAS

Risk factors: age, hypertension, DM, obesity

some studies: age, HT, obesity

NR

HT (SHRSP)

NA

HHCy

HT, dietary risk factors (high fat, high salt); hypo-perfusion

HT

Age (obesity?)

Notch3 mutation

Co-morbidities e.g., mutant APP

Brain gross pathology: atrophy, large infarcts..

Focal ischaemic lesion; cortical and striatal

Focal ischaemic lesion; atrophy and pseudo-cyst in chronic stage

NA

NA

NA

Ischaemic lesions and He; variable extent, location

NA

Ventricles enlarged; brain atrophy; spontaneous lesions

NR

Brain neuropathology: Lacunes/micro-Hge, micro-bleeds, diffuse WML

Rapid cell death in ischaemic core. Leukocyte infiltration, neuro-inflammatory changes. Delayed damage in remote areas.

acute cell death in core; inflammatory response; lepto-meningeal and vascular re-organisation; delayed neuroinflammatory response in remote areas

Diffuse WML; micro-Hge; Impaired BBB; microglial activation;

Diffuse WML; microglial activation; Impaired BBB

Micro-Hge in some models

BBB changes, neuro-inflammation.

Focal micro-infarcts; No diffuse WML

Aβ plaques, hippocampal neuronal loss, gliosis, micro-Hge

WML - vacuolisation; focal lesions in some aged animals

Diffuse WML in animals with UCCAo

Small vessel changes: Arteriolosclerosis, BBB dysfunction, CAA

NA

NR

CAA in some models

NA

CAA, micro-vascular rarefaction; BBB dysfunction in some models

BBB dysfunction (some studies)

Increased tortuosity

CAA. BBB dysfunction (on MRI)

GOM deposits, impaired CVR; BBB dysfunction (some studies)

  1. Clinical and pathological aspects of VCI are summarised in the first column. How selected animal models relate to these is summarised in the succeeding columns
  2. Abbreviations: BBB blood–brain-barrier, CVR cerebrovascular reactivity, GOM granular osmiophilic material, Hge haemorrhage, HHCy hyperhomocysteinemia, HT hypertension, NA not applicable, NR not reported, SHRSP stroke-prone spontaneously hypertensive rats, UCCAo unilateral common carotid artery occlusion WML white matter lesions